SPOT CARE BLUE ONE by Leejiham 80395-203

SPOT CARE BLUE ONE by

Drug Labeling and Warnings

SPOT CARE BLUE ONE by is a Otc medication manufactured, distributed, or labeled by Leejiham. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPOT CARE BLUE ONE- alcohol, lactic acid, salicylic acid, benzyl alcohol, glycerin liquid 
Leejiham

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

80395-203

Active ingredient

Alcohol 80%

Lactic Acid 0.9%

Salicylic Acid 0.45%

Glycerin 0.02%

Benzyl Alcohol 0.1%

Purpose

Skin Protectant

Acne

Uses

Water type ampule for acne skin caused by excessive sebum and dead skin cells clogging pores.

Directions

After cleansing, soak cotton butt or cotton pad and apply on acnes.

Inactive ingredients

Alcohol, Water, Lactic Acid, Candida Bombicola/Glucose/Methyl Rapeseedate Ferment, Salicylic Acid, Phytosphingosine, Glycerin, Panthenol, Hydrogenated Lecithin, Niacinamide, Raffinose, Ceramide NP, Cholesterol, Hydrogenated Starch Hydrolysate, Glycosyl Trehalose, Ethylhexylglycerin, Silkworm Extract, Scutellaria Baicalensis Root Extract, Illicium Verum (Anise) Fruit Extract, 1,2-Hexanediol, PEG-60 Almond Glycerides, Caprylyl Glycol, Carbomer, Butylene Glycol, Nordihydroguaiaretic Acid, Oleanolic Acid, Benzyl Alcohol

Warnings

For external use only

Stop use and ask a physician

if skin irritation and redness occurs more than 72 hours.

Do not use

on damaged or broken skin

Keep out of reach of children

If swallowed, get medical help right away.

Other information

Protect this product from direct sun and excessive heat

Package Label

30ml NDC: <a href=/NDC/80395-203-01>80395-203-01</a> Label 1

30ml NDC: <a href=/NDC/80395-203-01>80395-203-01</a> Label 2

50ml NDC: <a href=/NDC/80395-203-02>80395-203-02</a> Label

SPOT CARE BLUE ONE 
alcohol, lactic acid, salicylic acid, benzyl alcohol, glycerin liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 80395-203
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LACTIC ACID (UNII: 33X04XA5AT) (LACTIC ACID - UNII:33X04XA5AT) LACTIC ACID0.9 g  in 100 mL
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN0.02 g  in 100 mL
ALCOHOL (UNII: 3K9958V90M) (ALCOHOL - UNII:3K9958V90M) ALCOHOL80 mL  in 100 mL
BENZYL ALCOHOL (UNII: LKG8494WBH) (BENZYL ALCOHOL - UNII:LKG8494WBH) BENZYL ALCOHOL0.1 g  in 100 mL
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID0.45 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
SCUTELLARIA BAICALENSIS ROOT (UNII: 7J95K7ID2S)  
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
PANTHENOL (UNII: WV9CM0O67Z)  
NIACINAMIDE (UNII: 25X51I8RD4)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
NORDIHYDROGUAIARETIC ACID, (+/-)- (UNII: 7PZ73W4ZNR)  
BOMBYX MORI LARVA (UNII: 1WYM0QWX33)  
OLEANOLIC ACID (UNII: 6SMK8R7TGJ)  
CERAMIDE NP (UNII: 4370DF050B)  
BEMISIOSE (UNII: 76B4LOB2YC)  
WATER (UNII: 059QF0KO0R)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
HYDROGENATED SOYBEAN LECITHIN (UNII: H1109Z9J4N)  
SODIUM CITRATE (UNII: 1Q73Q2JULR)  
CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
RAFFINOSE (UNII: N5O3QU595M)  
PEG-60 ALMOND GLYCERIDES (UNII: 4Y0E651N0F)  
STAR ANISE FRUIT (UNII: CK15HA8438)  
SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
HYDROGENATED STARCH HYDROLYSATE (UNII: 27F77DSJ5V)  
PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
BIOTIN (UNII: 6SO6U10H04)  
CHOLESTEROL (UNII: 97C5T2UQ7J)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 80395-203-0130 mL in 1 BOTTLE; Type 0: Not a Combination Product09/02/202012/31/2021
2NDC: 80395-203-0250 mL in 1 BOTTLE; Type 0: Not a Combination Product09/02/202012/31/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34709/02/202012/31/2021
Labeler - Leejiham (695004132)
Registrant - Leejiham (695004132)
Establishment
NameAddressID/FEIBusiness Operations
Leejiham695004132manufacture(80395-203)

Revised: 6/2022

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.